LeMaitre Vascular, Inc. carries a market capitalization of 2.13B, placing it among publicly traded companies globally. Its enterprise value stands at 2.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.13B |
| Enterprise Value | 2.30B |
LeMaitre Vascular, Inc. currently has 22.85M shares outstanding.
| Shares Outstanding | 22.85M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
LeMaitre Vascular, Inc. trades at a trailing price-to-earnings ratio of 39.71. The price-to-sales ratio is 9.67, and the price-to-book ratio stands at 12.71.
| PE Ratio | 39.71 |
| PS Ratio | 9.67 |
| PB Ratio | 12.71 |
| P/TBV Ratio | 8.02 |
| P/FCF Ratio | 26.66 |
| P/OCF Ratio | 28.38 |
On an enterprise value basis, LeMaitre Vascular, Inc. trades at an EV/EBITDA multiple of 27.53 and an EV/FCF ratio of 23.12. The EV/Sales ratio of 8.98 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 31.48 provides insight into valuation relative to core operating earnings.
| EV / Sales | 8.98 |
| EV / EBITDA | 27.53 |
| EV / EBIT | 31.48 |
| EV / FCF | 23.12 |
LeMaitre Vascular, Inc. maintains a current ratio of 14.32, meaning it holds 14.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 46.68, indicating elevated leverage, while an interest coverage ratio of 16.09 demonstrates strong ability to service its debt obligations.
| Current Ratio | 14.32 |
| Quick Ratio | 12.08 |
| Debt / Equity | 46.68 |
| Debt / EBITDA | 2.27 |
| Interest Coverage | 16.09 |
LeMaitre Vascular, Inc. posts a return on equity of 35.99 and a return on invested capital of 9.80.
| Return on Equity (ROE) | 35.99 |
| Return on Assets (ROA) | 10.53 |
| Return on Invested Capital (ROIC) | 9.80 |
| Return on Capital Employed (ROCE) | 18.40 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.24 |
Over the trailing twelve months, LeMaitre Vascular, Inc. has paid 18.21M in income taxes, reflecting an effective tax rate of 22.59.
| Income Tax | 18.21M |
| Effective Tax Rate | 22.59 |
LeMaitre Vascular, Inc.'s stock has gained approximately 15.28206% over the past 52 weeks. The 50-day moving average sits at 103.80, while the 200-day moving average is 94.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | 15.28206% |
| 50-Day Moving Average | 103.80 |
| 200-Day Moving Average | 94.33 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, LeMaitre Vascular, Inc. generated 256.28M in revenue and converted that into 62.40M in net income, yielding earnings per share of 2.68. EBITDA reached 83.55M, while operating income came in at 73.06M.
| Revenue | 256.28M |
| Gross Profit | 185.52M |
| Operating Income | 73.06M |
| Pretax Income | 80.62M |
| Net Income | 62.40M |
| EBITDA | 83.55M |
| EBIT | 73.06M |
| Earnings Per Share (EPS) | 2.68 |
LeMaitre Vascular, Inc. holds 367.23M in cash and equivalents against 189.82M in total debt, resulting in a net debt position of 142.02M. Total book value stands at 194.93M, with working capital of 444.45M providing operational flexibility.
| Cash & Cash Equivalents | 367.23M |
| Total Debt | 189.82M |
| Net Debt | 142.02M |
| Equity (Book Value) | 194.93M |
| Book Value Per Share | 8.59 |
| Working Capital | 444.45M |
LeMaitre Vascular, Inc. produced 87.31M in operating cash flow over the past twelve months. After subtracting -8.18M in capital expenditures, free cash flow totaled 79.12M - equivalent to 3.49 per share.
| Operating Cash Flow | 87.31M |
| Capital Expenditures | -8.18M |
| Free Cash Flow | 79.12M |
| FCF Per Share | 3.49 |
LeMaitre Vascular, Inc. operates with a gross margin of 72.39, reflecting its pricing power and cost economics. The operating margin of 28.51 and net profit margin of 24.35 provide insight into operational efficiency.
| Gross Margin | 72.39 |
| Operating Margin | 28.51 |
| Pretax Margin | 31.46 |
| Profit Margin | 24.35 |
| EBITDA Margin | 32.60 |
The company's payout ratio of 30.93 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.85 |
| Dividend Yield | N/A |
| Payout Ratio | 30.93 |
| Shareholder Yield | 0.51 |
| FCF Yield | 3.75 |
LeMaitre Vascular, Inc. posts an Altman Z-Score of 9.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.12 |